Study shows new oral COVID-19 treatment from Merck reduces risk of hospitalization and death
A new study shows an oral COVID-19 treatment from Merck reduces the risk of hospitalization and death. CBS News medical contributor, Dr. David Agus joins “CBS Mornings” to discuss.